Research Topics
| Anna Bill-AxelsonSummaryAffiliation: Uppsala University Country: Sweden Publications
|
Detail Information
Publications
Psychiatric treatment in men with prostate cancer--results from a Nation-wide, population-based cohort study from PCBaSe SwedenAnna Bill-Axelson
Department of Urology, University Hospital, Uppsala, Sweden
Eur J Cancer 47:2195-201. 2011..To explore whether the self-reported psychological distress among men with prostate cancer was to the extent that it required psychiatric treatment...
Radical prostatectomy versus watchful waiting in early prostate cancerAnna Bill-Axelson
Department of Urology, University Hospital, Uppsala, Sweden
N Engl J Med 364:1708-17. 2011..In 2008, we reported that radical prostatectomy, as compared with watchful waiting, reduces the rate of death from prostate cancer. After an additional 3 years of follow-up, we now report estimated 15-year results...
Radical prostatectomy versus watchful waiting in early prostate cancerAnna Bill-Axelson
Department of Urology, University Hospital, Uppsala, Sweden
N Engl J Med 352:1977-84. 2005..In 2002, we reported the initial results of a trial comparing radical prostatectomy with watchful waiting in the management of early prostate cancer. After three more years of follow-up, we report estimated 10-year results...
Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe SwedenAnna Bill-Axelson
Department of Urology, University Hospital, Uppsala, Sweden
Eur Urol 57:390-5. 2010..The risk of suicide is increased among cancer patients including men with prostate cancer (PCa). However, whether this increased risk applies to men diagnosed subsequent to prostate-specific antigen (PSA) testing is not known...
Experiences of randomization: interviews with patients and clinicians in the SPCG-IV trialAnna Bill-Axelson
Department of Urology, Uppsala University Hospital, Uppsala, Sweden
Scand J Urol Nephrol 42:358-63. 2008..This study investigated patients' and clinicians' experiences of randomization with the aim of facilitating trial participation in the future...
Effects of prostate-specific antigen testing on familial prostate cancer risk estimatesOla Bratt
Department of Urology, Helsingborg Hospital, Helsingborg, Sweden
J Natl Cancer Inst 102:1336-43. 2010..Family history is a strong risk factor for prostate cancer. The aim of this study was to investigate whether increased diagnostic activity is related to the incidence of prostate cancer among brothers of men with prostate cancer...
Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trialEva Johansson
Department of Surgical Sciences, University Hospital of Uppsala, Uppsala, Sweden
Lancet Oncol 12:891-9. 2011..We report results for quality of life for men in the Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) after a median follow-up of more than 12 years...
Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trialAnna Bill-Axelson
Department of Urology, University Hospital, Uppsala, Sweden
J Natl Cancer Inst 100:1144-54. 2008..In 2005, we reported that radical prostatectomy improved prostate cancer survival compared with watchful waiting after a median of 8.2 years of follow-up. We now report results after 3 more years of follow-up...
A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancerLars Holmberg
Regional Oncologic Center, University Hospital, Uppsala, Sweden
N Engl J Med 347:781-9. 2002..41 to 0.96). CONCLUSIONS: In this randomized trial, radical prostatectomy significantly reduced disease-specific mortality, but there was no significant difference between surgery and watchful waiting in terms of overall survival...
Prognostic markers under watchful waiting and radical prostatectomyLars Holmberg
Regional Oncologic Center, University Hospital, Uppsala, Sweden
Hematol Oncol Clin North Am 20:845-55. 2006..Because overall prognostic information obtained by these parameters or by tumor stage was not provided in our publication, we now present these data in the two study arms separately...
Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of SwedenOla Bratt
Department of Urology, Helsingborg Hospital, Lund University, Sweden
Scand J Urol Nephrol 44:384-90. 2010..To investigate the effects of prostate-specific antigen (PSA) testing of men without clinical signs of prostate cancer on the incidence of prostate cancer in Sweden...
Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trialEva Johansson
Department of Urology, Uppsala University Hospital, Uppsala, Sweden
Eur Urol 55:422-30. 2009..Quality-of-life outcomes are important in the choice of treatment strategy for men with localized prostate cancer...
No increased prostate cancer incidence after negative transrectal ultrasound guided multiple biopsies in men with increased prostate specific antigen and/or abnormal digital rectal examinationAnna Bill-Axelson
Department of Urology, Uppsala University Hospital, Uppsala, Sweden
J Urol 170:1180-3. 2003..We investigated the incidence of prostate cancer after negative transrectal ultrasound (TRUS) guided multiple biopsies. Our secondary aim was to calculate the sensitivity of the extended protocol used...
Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005Jan Adolfsson
Oncological Centre, Karolinska University Hospital, CLINTEC, Karolinska Institute, Stockholm, Sweden
Scand J Urol Nephrol 41:456-77. 2007..The incidence of prostate cancer is rising rapidly in Sweden and there is a need to better understand the pattern of diagnosis, tumor characteristics and treatment...
Prostate-specific antigen levels as a predictor of lethal prostate cancerKatja Fall
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, S 171 77 Stockholm, Sweden
J Natl Cancer Inst 99:526-32. 2007..Rates of long-term survival among patients with untreated localized prostate cancer are high. To avoid unnecessary treatment, tools are needed to identify the small proportion of patients who are destined to develop lethal prostate cancer...
[Radical prostatectomy reduces the risk of death in prostatic cancer. The effect on total mortality can not be established yet as shown in a randomized controlled trial]Anna Bill-Axelson
Urologiska kliniken, Akademiska sjukhuset, Uppsala
Lakartidningen 100:1714-6. 2003
